GRN and neoplasm: In the multivariate analysis adjusted for tumor stage and Gleason score, GP88 staining appeared to be an independent prognostic factor for OS (p = 0.004), DSS (p = 0.008) and RFS (p = 0.003) in patients 65 years old and younger.